Add-on Acquisition • Life Science

XtalPi Acquires LCC Therapeutics

On June 13, 2025, XtalPi acquired life science company LCC Therapeutics from Maven Capital Partners

Acquisition Context
  • This is XtalPi’s 1st transaction in the Life Science sector.
  • This is XtalPi’s 1st transaction in the United Kingdom.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date June 13, 2025
Target LCC Therapeutics
Sector Life Science
Buyer(s) XtalPi
Sellers(s) Maven Capital Partners
Deal Type Add-on Acquisition

Target Company

LCC Therapeutics

Runcorn, United Kingdom
LCC Therapeutics is an international chemical technology business whose products form the building blocks to the research and development of new drugs. LCC Therapeutics was founded in 2014 and is based in Runcorn, United Kingdom.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

XtalPi

Shenzhen, China

Category Company
Founded 2015
Sector Life Science
Employees809
Revenue 266M CNY (2024)
DESCRIPTION

XtalPi is an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. XtalPi was founded in 2015 and is headquartered in Shenzhen, China.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Add-on Acquisition 1 of 1
Country: United Kingdom 1 of 1
Year: 2025 1 of 1

Seller Profile 1

SELLER

Maven Capital Partners

Glasgow, United Kingdom

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 2009
PE ASSETS 760M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Maven Capital Partners UK LLP (MCP) invests in lower mid-market companies throughout the UK. The Firm also provides mezzanine financing. MCP focuses on profitable companies with proven track records, balanced management teams, and diverse products and services. Maven looks to invest £2 - £20 million in businesses valued from £10 - £40 million. Sectors of interest include specialist manufacturing, health/pharmaceuticals, energy services, leisure, financial services, software and computer services, communication/IT, chemicals, food/beverage, media, consumer products, and support services. Types of transactions include MBOs, MBIs, BIMBOs, take privates, recapitalizations, and growth capital financings. Maven Capital Partners UK LLP was formed in 2009, following a management buyout of Aberdeen Asset Management's Private Equity division. Maven is based in Glasgow with additional offices in Aberdeen, Birmingham, Edinburgh, London and Manchester.


Deal Context for Seller #
Overall 84 of 86
Sector: Life Science 7 of 7
Type: Add-on Acquisition 39 of 40
Country: United Kingdom 82 of 84
Year: 2025 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-24 KubeNet

Glasgow, United Kingdom

KubeNet is a technology solutions provider specialising in managed IT & infrastructure services, cloud solutions, connectivity, voice, and cybersecurity. KubeNet is based in Glasgow, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-06-30 Oak Engage

Newcastle upon Tyne, United Kingdom

Oak Engage develops and sells intranet solutions through its cloud-based platform. Oak Engage was founded in 1994 and is based in Newcastle upon Tyne, United Kingdom.

Sell -